We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OKYO market cap is 37.52M. The company's latest EPS is GBP -0.1558 and P/E is -9.44.
| Quarter End | |||||
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -837k | -3.47M | -1.22M | -2.16M | -3.73M |
| Net Income | -53.15M | -3.76M | -1.21M | -2.26M | -3.98M |
| Quarter End | |||||
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 2.01M | 583k | 483k | 5.14M | 3.27M |
| Total Liabilities | 91k | 328k | 596k | 1.28M | 1.03M |
| Total Equity | 1.92M | 255k | -113k | 3.85M | 2.24M |
| Market Cap | 37.52M |
| Price to Earnings Ratio | -9.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.24 |
| Price to Book Ratio | 16.73 |
| Dividend Yield | - |
| Shares Outstanding | 25.52M |
| Average Volume (1 week) | 31.6k |
| Average Volume (1 Month) | 27.09k |
| 52 Week Change | 14.85% |
| 52 Week High | 3.25 |
| 52 Week Low | 0.9201 |
| Spread (Intraday) | 0.11 (6.96%) |
| Company Name | OKYO Pharma Ltd |
| Address |
martello court guernsey GY1 3HB |
| Website | https://www.okyopharma.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
